Massimo Group: Form 10-K for the period ended Dec 31, 2024
Filed with the SEC on Mar 26, 2025 and accepted by EDGAR at Mar 26, 2025, 16:36 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $111.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 12 months2024-01-01 to 2024-12-31 | $34.3m | us-gaap:GrossProfit |
| Research and development | 12 months2024-01-01 to 2024-12-31 | $343.5k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2024-01-01 to 2024-12-31 | $6.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2024-01-01 to 2024-12-31 | $98.7k | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2024-01-01 to 2024-12-31 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-01-01 to 2024-12-31 | $3.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | $0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 41,161,849 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | $6.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | $387.9k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2024-12-31 | $45.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $56.7m | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $26.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-12-31 | $33.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-12-31 | $23.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001641172-25-000763. Last ingested by Listed: Nov 3, 2026, 08:27 ET. Listed shows no prices and gives no investment advice.